Previous Close | 0.0040 |
Open | 0.0061 |
Bid | 0.0055 x 0 |
Ask | 0.0070 x 0 |
Day's Range | 0.0060 - 0.0097 |
52 Week Range | 0.0036 - 0.0750 |
Volume | |
Avg. Volume | 142,780 |
Market Cap | 590,407 |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings Date | Nov 25, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Apr 10, 1996 |
1y Target Est | N/A |
North Bergen, New Jersey--(Newsfile Corp. - October 31, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) is pleased to announce a joint venture and distribution partnership with Reveal Lasers LLC to expand the reach of Evolutionary Biologics, Inc.'s biologic products across the aesthetic and regenerative health market. This collaboration will position Evolutionary Biologics' premium biologic solutions within Reveal Lasers' extensive distribution channels, allowing Plastic Surgeons, Dermatologis
North Bergen, New Jersey--(Newsfile Corp. - October 29, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) - Evolutionary Biologics is pleased to have Dr. Goldberg as a speaker at EvoBio's webinar on regenerative biologics. With extensive experience in regenerative medicine, Dr. Goldberg will shed light on why Evolutionary Biologics, Inc.'s exosomes lead the way in advancing patient care.Jim Morrison, CEO and President of Apollo Biowellness, Inc., stated, "Dr. David Goldberg, is an icon in ...